Clinical Trial Update: 48 Weeks, Study to Evaluate Overall Safety and Tolerability of Co-administration of Tesofensine and Metoprolol in Subjects With Hypothalamic Injury-induced Obesity (HIO) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and tolerability of co-administering tesofensine and metoprolol in hypothalamic injury-induced obesity; study completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypothalamic Injury-induced Obesity

Drugs mentioned

• METOPROLOL (METOPROLOL TARTRATE)
• Tesofensine (tesofensine)

Snippet

Sponsor: Saniona | Conditions: Hypothalamic Injury-induced Obesity (HIO) | Phase 2 | Status: COMPLETED | Results posted: 2024-02-13